Onyx to Invest in Continuous Flow Technology

News   Jun 26, 2014

 
Onyx to Invest in Continuous Flow Technology
 
 
 

RELATED ARTICLES

PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets

News

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

READ MORE

‘Coffee Filter’ Makes Production of Cancer Drug Much Cheaper

News

Making drugs cheaper doesn't always require pricey investments. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen.

READ MORE

Construction of State-of-the-Art Flow Chemistry Facility Commences

News

Construction has commenced on a new $8 million Centre for Industrial Flow Chemistry at the CSIRO’s Normanby Rd Clayton site. The purpose-built, 410m2 state-of-the-art facility will provide local manufacturers access to CSIRO’s flow chemistry technology.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE